Mar 22, 2024 02:00AM
Dec 27, 2022 08:30AM
Oct 3, 2022 08:33AM
Oct 3, 2022 08:30AM
Aug 12, 2022 08:33AM
Aug 12, 2022 08:30AM
Jul 28, 2022 08:33AM Acer Therapeutics (ACER) and Relief Therapeutics Announce ACER-001 IND Submission for the Treatment of Maple Syrup Urine Disease
Jul 28, 2022 08:33AM
Jul 28, 2022 08:30AM
Jul 8, 2022 08:30AM
Jun 21, 2022 08:30AM
May 6, 2022 08:30AM
Apr 12, 2022 08:30AM
Jan 27, 2022 08:30AM Acer Therapeutics and Relief Therapeutics Announce Presentation of Four ACER-001 Posters at the Upcoming SIMD and GMDI Conferences
Oct 7, 2021 08:33AM
Oct 7, 2021 08:30AM
Oct 6, 2021 08:31AM
Oct 6, 2021 08:30AM
Aug 9, 2021 08:31AM
Aug 9, 2021 08:30AM
Aug 3, 2021 05:31AM Relief Therapeutics (RLFTF) RLF-100 (aviptadil) Receives FDA Orphan Drug Designation
Aug 3, 2021 01:03AM
May 25, 2021 08:33AM
May 25, 2021 08:30AM
May 25, 2021 06:50AM
May 25, 2021 06:48AM
Apr 6, 2021 01:01AM
Mar 29, 2021 01:05AM /C O R R E C T I O N -- NeuroRx/
Mar 29, 2021 01:05AM
Mar 22, 2021 08:30AM
Feb 23, 2021 01:11PM
Feb 9, 2021 08:13AM
Feb 9, 2021 07:30AM
Jan 25, 2021 08:41AM
Jan 25, 2021 08:35AM Relief Therapeutics and Acer Therapeutics Sign Option Agreement for Exclusivity to Negotiate a Collaboration and License Agreement for the Worldwide Development and Commercialization of ACER-001 for
Jan 11, 2021 01:00AM
Dec 30, 2020 01:00AM
Apr 2, 2020 02:16AM
Aug 12, 2019 01:20AM

1,182,431 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All